MEASURING FOREARM BONE MINERAL DENSITY (BMD) IN ELDERLY FEMALE PATIENTS (PTS): DOES IT ADD VALUE FOR THE DIAGNOSIS OF OSTEOPOROSIS?

被引：0
|
作者：
Chun, K. [1 ]
Miller, T. S. [1 ]
Green, D. J. [1 ]
Coco, M. [2 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Internal Med, Div Nephrol, Bronx, NY 10467 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P700
引用
下载
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [31] Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates
    Heckman, GA
    Papaioannou, A
    Sebaldt, RJ
    Ioannidis, G
    Petrie, A
    Goldsmith, C
    Adachi, JD
    BMC MUSCULOSKELETAL DISORDERS, 2002, 3 (1) : 1 - 6
  • [32] The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis
    Kaji, H
    Yamauchi, M
    Chihara, K
    Sugimoto, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 27 - 34
  • [33] OSTEOPOROSIS AND RISK OF LOW BONE MINERAL DENSITY IN UNTREATED FEMALE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Josifoska, S. T. J. Tofiloska
    Prosheva, T. B. P. Bajraktarova
    Jordanova, S. J.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S449 - S449
  • [34] Comparison between the Klemetti index and heel DXA BMD measurements in the diagnosis of reduced skeletal bone mineral density in the elderly
    Anders Halling
    G. Rutger Persson
    Johan Berglund
    Owe Johansson
    Stefan Renvert
    Osteoporosis International, 2005, 16 : 999 - 1003
  • [35] Comparison between the Klemetti index and heel DXA BMD measurements in the diagnosis of reduced skeletal bone mineral density in the elderly
    Halling, A
    Persson, GR
    Berglund, J
    Johansson, O
    Renvert, S
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (08) : 999 - 1003
  • [36] Factors related to the response rate of bone mineral density (BMD) to osteoanabolic therapy (teriparatide/PTH) in patients with severe osteoporosis
    Gifre, Laia
    Monegal, Ana
    Filella, Xavier
    Muxi, Africa
    Guanabens, Nuria
    Peris, Pilar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S321 - S321
  • [37] Zoledronic acid (ZOL) markedly improves bone mineral density (BMD) for patients (Pts) with monoclonal gammopathy of undetermined significance (MGUS) and bone loss
    Berenson, James R.
    Yellin, Ori
    Boccia, Ralph V.
    Flam, Marshall S.
    Wong, Siu-Fun
    Batuman, Olcay
    Moezi, Mehdi M.
    Woytowitz, Donald
    Duvivier, Herb
    Nassir, Youram
    Swift, Regina A.
    BLOOD, 2007, 110 (11) : 1055A - 1055A
  • [38] Does parathyroid hormone treatment affect fracture risk or bone mineral density in patients with osteoporosis?
    Compston, Juliet
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (06): : 324 - 325
  • [39] Anastrozole does not cause osteoporosis in breast cancer patients with normal bone mineral density at outset
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 941 - 941
  • [40] Does parathyroid hormone treatment affect fracture risk or bone mineral density in patients with osteoporosis?
    Juliet Compston
    Nature Clinical Practice Rheumatology, 2007, 3 : 324 - 325
12345